Nemluvio’s approval was based on positive results from the Phase 3 OLYMIA trial, which showed significant reduction in itch.
FDA approves Galderma’s Nemrubio for adults with prurigo nodularis
Leave a comment
Nemluvio’s approval was based on positive results from the Phase 3 OLYMIA trial, which showed significant reduction in itch.
